Dr. Bernard Le Foll, clinician scientist, addictions researcher, and member of the Women’s Health Research Cluster, has been elected as a Fellow of the Canadian Academy of Health Sciences (CAHS), one of the highest honours in Canadian health research. This prestigious recognition celebrates his leadership in advancing evidence-based approaches to addiction medicine, integrating research into clinical care, and shaping public health policy. His work has contributed to a deeper understanding of how sex and gender influence addiction, supporting the development of more responsive and equitable treatment strategies.
Election to the CAHS is reserved for leaders whose work has made a sustained and transformative impact on health and health systems in Canada. Dr. Le Foll is internationally recognized for his pioneering work on nicotine and substance use, and for advancing clinical guidelines and policy frameworks that improve treatment for people living with addiction.
Working with several trainees in his laboratory, he has published several manuscripts examining sex and gender differences in substance use and treatment response, helping to build a stronger evidence base for more tailored and inclusive care. His leadership in bridging research with real-world clinical settings has positioned him as a trusted voice in national addiction policy discussions, including testimony to Canadian parliamentary committees.
Dr. Le Foll’s election to CAHS highlights not only his scientific excellence but also his sustained impact on the broader Canadian health system.
Dr. Le Foll’s achievement reflects the research excellence and leadership within the Women’s Health Research Cluster. To learn more about the CAHS Fellows program, visit https://cahs-acss.ca, or explore Dr. Le Foll’s research in his Cluster profile.
